Allen F. Ryan
Corporate Officer/Principal bei Washington University in St. Louis
Aktive Positionen von Allen F. Ryan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Washington University in St. Louis | Corporate Officer/Principal | - | - |
Karriereverlauf von Allen F. Ryan
Ehemalige bekannte Positionen von Allen F. Ryan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OTONOMY | Gründer | 01.04.2008 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Allen F. Ryan
- Erfahrung
